Quest PharmaTech Inc. (CVE:QPT – Get Free Report) hit a new 52-week low on Wednesday . The stock traded as low as C$0.02 and last traded at C$0.02, with a volume of 10300 shares traded. The stock had previously closed at C$0.02.
Quest PharmaTech Price Performance
The company has a 50-day moving average price of C$0.02 and a two-hundred day moving average price of C$0.03. The company has a debt-to-equity ratio of 4.49, a current ratio of 0.54 and a quick ratio of 0.52. The company has a market cap of C$2.54 million, a PE ratio of -1.00 and a beta of 0.10.
Quest PharmaTech (CVE:QPT – Get Free Report) last issued its earnings results on Friday, June 28th. The company reported C($0.01) earnings per share for the quarter.
Quest PharmaTech Company Profile
Quest PharmaTech Inc, a pharmaceutical company, engages in the development of novel therapeutics for the treatment of targeted cancer. Its lead product candidate is Mab AR 9.6 against truncated O-glycan on MUC16, for targeted cancer therapy applications. The company also offers Oregovomab, which is in Phase III clinical trial for the treatment of ovarian cancer.
Recommended Stories
- Five stocks we like better than Quest PharmaTech
- What Does a Stock Split Mean?
- BHP Stock: The Under-the-Radar Growth Story in Commodities
- How to Choose Top Rated Stocks
- Analysts Upgrade These 3 Hot Buy-and-Hold Stocks
- 3 Ways To Invest In Coffee, Other Than Drinking It
- Kohl’s Charts a Resilient Path in a Challenging Retail Landscape
Receive News & Ratings for Quest PharmaTech Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Quest PharmaTech and related companies with MarketBeat.com's FREE daily email newsletter.
